Page 2 - Jay Wohlgemuth News Today

On Sept. 7, Quest Diagnostics announced its monkeypox test received emergency use authorization from the FDA for use by authorized labs. 

Quest Diagnostics announced July 13 that its molecular diagnostic test for the monkeypox virus is now available nationwide.

As the country moves toward normalcy, many people who have been infected, vaccinated or both, want to know their level of protection against a future variant, and whether it has waned over time. A test to gauge antibody levels can be a powerful tool to measure individual risk, but scientists warn that there is no magic number that guarantees you are fully protected.

Leaders from various sectors of health care discussed telehealth, nursing shortages, and workplace issues at the 11th annual Business of Health Care Conference held last week at the University of Miami and livestreamed to more than a thousand viewers.

Labs preparing for increase in POC, home testing post-pandemic Adam Bonislawski, 360Dx Dan DeLong for KHN A clinical lab technician at the UW Medicine Virology laboratory in Seattle processes patient samples for COVID-19 on March 11, 2020. COVID-19 has driven an uptick in healthcare delivery approaches like telemedicine and point-of-care, home, and direct-to-consumer testing, a shift that some observers believe could continue to accelerate even after the pandemic is over. It is a trend that has...

Quest Diagnostics wins CDC contract to sequence coronavirus samples Associated Press YORK — Quest Diagnostics said Monday that it has secured a contract from the U.S. Centers for Disease Control and Prevention to provide genomic sequencing of SARS-CoV-2. Financial and other terms of the agreement were not disclosed. The aim of the project is to identify novel mutations in the virus and to better understand its prevalence and patterns of transmission throughout the US. Quest will sequence the ...